Form4.ai tracks every SEC insider trade in real time. See every MPLT insider filing with a free account — no card.

See every MPLT insider filing

Free account

MapLight Therapeutics, Inc. (MPLT) Insider Trading

MapLight Therapeutics, Inc. (MPLT) has 13 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 7 sales totalling $1.3M. Most recent filing: Oct. 16, 2026.

Bought vs sold

Open-market value, last 90 days

Sold: $1.3M (100%)
  • Sold $1.3M · 100%

What insiders filed

Form 4 filings by type, last 90 days

Sales: 7 (54%) Grants, exercises & other: 6 (46%)
  • Sales 7 · 54%
  • Grants, exercises & other 6 · 46%

At a glance

Insiders trading
6
Largest buy
—
Most recent filing
Oct 16, 2026

Latest MPLT Form 4 filings

Date Insider Trade Value Price since buy
Oct 16, 2026 SEC filing GILLIS JONATHAN CAO and Interim CFO Sold $82,149 —
Oct 16, 2026 SEC filing Kreitzer Anatol Chief Discovery Officer Sold $96,024 —
Oct 16, 2026 SEC filing Foff Erin Pennock Chief Medical Officer Sold $124,068 —

See every MPLT insider trade

Create a free account to see all 13 MPLT filings from the last 90 days. No card needed.

Create free account

Want MPLT insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days

Insiders are buying right now in other stocks too. See the latest insider trades across the market.

About this data

Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.